 Home > Medical News > Latest Medical News > Watson Bio's bivalent HPV vaccine is about to be approved

Watson Bio's bivalent HPV vaccine is about to be approved

 Last Update: 2022-05-28
 Source: Internet
 Author: User

Tags

kingdom

northeast united states

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Recently, the official website of NMPA shows that the recombinant human papillomavirus bivalent (type 16/18) vaccine of Yuxi Zerun Bio, a subsidiary of Watson Bio, has begun administrative approval and is expected to be approved for marketing in the near future

The bivalent HPV vaccine developed by Shanghai Zerun is used to prevent cervical cancer caused by HPV16 and 18 virus infection

In terms of development time, this bivalent HPV vaccine was approved for clinical trials as early as June 1, 2011

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.